BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1675752)

  • 1. Epstein-Barr virus latent genes in tumour cells of Hodgkin's disease.
    Young LS; Deacon EM; Rowe M; Crocker J; Herbst H; Niedobitek G; Hamilton-Dutoit SJ; Pallesen G
    Lancet; 1991 Jun; 337(8757):1617. PubMed ID: 1675752
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein.
    Vestlev PM; Pallesen G; Sandvej K; Hamilton-Dutoit SJ; Bendtzen SM
    Int J Cancer; 1992 Feb; 50(4):670-1. PubMed ID: 1311289
    [No Abstract]   [Full Text] [Related]  

  • 3. High incidence of Epstein-Barr virus genomes in Hodgkin's disease.
    Herbst H; Niedobitek G; Kneba M; Hummel M; Finn T; Anagnostopoulos I; Bergholz M; Krieger G; Stein H
    Am J Pathol; 1990 Jul; 137(1):13-8. PubMed ID: 2164775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of the detection of Epstein-Barr virus DNA in lymph nodes in patients with Hodgkin's disease.
    Knecht H; Joske DJ; Bachmann E; Sahli R; Odermatt BF
    Leuk Lymphoma; 1992 Nov; 8(4-5):319-25. PubMed ID: 1337849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus infection: aetiological role versus coincidental event in Hodgkin's disease.
    Lardelli P; Cisterna R; Anton I; Garcia del Moral R
    J Pathol; 1992 May; 167(1):91-2. PubMed ID: 1320671
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr virus burden in Hodgkin's disease is related to latent membrane protein gene expression but not to active viral replication.
    Joske DJ; Emery-Goodman A; Bachmann E; Bachmann F; Odermatt B; Knecht H
    Blood; 1992 Nov; 80(10):2610-3. PubMed ID: 1384793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-existence of the A and B types of Epstein-Barr virus DNA in lymph node biopsies from Algerian patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    Bouzid M; Belkaid MI; Colonna P; Bouguermouh AM; Ooka T
    Leukemia; 1993 Sep; 7(9):1451-5. PubMed ID: 8396698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBV and Hodgkin's cells.
    Kubonishi I; Eguchi T; Kanzaki T; Muneishi H; Yano S; Ohtsuki Y; Miyoshi I
    Br J Haematol; 1990 Jun; 75(2):286-7. PubMed ID: 2164840
    [No Abstract]   [Full Text] [Related]  

  • 11. Epstein-Barr virus in Hodgkin's disease and site of origin of tumour.
    O'Grady J; Stewart S; Elton RA; Krajewski AS
    Lancet; 1994 Jan; 343(8892):265-6. PubMed ID: 7905098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Epstein-Barr virus genomes on patient survival in Hodgkin's disease.
    Fellbaum C; Hansmann ML; Niedermeyer H; Kraus I; Alavaikko MJ; Blanco G; Aine R; Busch R; Pütz B; Fischer R
    Am J Clin Pathol; 1992 Sep; 98(3):319-23. PubMed ID: 1326892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
    Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
    J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of latent membrane proteins (LMP) of Epstein-Barr virus in malignant lymphomas].
    Herbst H; Dallenbach F; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Jautzke G; Müller-Lantzsch N; Stein H
    Verh Dtsch Ges Pathol; 1991; 75():175-8. PubMed ID: 1724825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of Epstein-Barr virus nuclear antigen 2 in tumour cells of Hodgkin's disease.
    Brousset P; Chittal S; Roya L; Delsol G
    Lancet; 1991 May; 337(8749):1107. PubMed ID: 1673537
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequent detection of Epstein-Barr viral deoxyribonucleic acid and absence of cytomegalovirus deoxyribonucleic acid in Hodgkin's disease and acquired immunodeficiency syndrome-related Hodgkin's disease.
    Samoszuk M; Ravel J
    Lab Invest; 1991 Dec; 65(6):631-6. PubMed ID: 1661351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus in Hodgkin's disease from patients with human immunodeficiency virus infection.
    Moran CA; Tuur S; Angritt P; Reid AH; O'Leary TJ
    Mod Pathol; 1992 Jan; 5(1):85-8. PubMed ID: 1311840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
    Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
    Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
    Delsol G; Brousset P; Chittal S; Rigal-Huguet F
    Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epstein-Barr virus and malignant lymphomas--studies on incidence and localization of viral DNA].
    Herbst H; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Bergholz M; Kneba M; Krieger G; Stein H
    Verh Dtsch Ges Pathol; 1990; 74():386-9. PubMed ID: 1708622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.